北京英诺特生物技术股份有限公司2024年年度权益分派实施公告

Core Points - The company announced a cash dividend of 0.56 RMB per share (including tax) for the 2024 fiscal year [2][4] - The dividend distribution plan was approved at the annual shareholders' meeting on May 22, 2025 [2][4] - The total number of shares eligible for profit distribution is 134,345,456 shares, resulting in a total cash dividend payout of approximately 75.23 million RMB (including tax) [4] Dividend Distribution Details - The cash dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the day before the equity registration date [3] - The company will not issue new shares or increase capital reserves during this dividend distribution [4][7] - The reference price for ex-dividend trading will be adjusted based on the cash dividend and the number of shares [7] Tax Implications - Individual shareholders holding unrestricted shares for over one year will be exempt from personal income tax on the dividend [11] - For shares held for less than one year, the company will not withhold tax at the time of distribution, but tax will be calculated and deducted upon the sale of the shares [11][12] - The actual cash dividend received by shareholders may vary based on their holding period and applicable tax rates [12][13] Share Buyback Program - The company adjusted the maximum buyback price from 50.00 RMB per share to 49.45 RMB per share, effective June 24, 2025 [16][18] - The buyback program aims to repurchase shares for employee stock ownership plans or equity incentives, with a total buyback amount between 50 million RMB and 100 million RMB [17][21] - The adjusted buyback price will allow for the repurchase of approximately 1,011,122 to 2,022,244 shares, representing 0.7410% to 1.4820% of the total share capital [21]